Approval · Notice of Compliance 7350 · 2005
BICNU: Notice of Compliance 7350
Issued September 2, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7350
- Date
- September 2, 2005
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BICNU | 00297763 | Marketed |
Medicinal ingredients
- CARMUSTINE 100 MG per VIAL